Effect of deep intramuscular stimulation and transcranial magnetic stimulation on neurophysiological biomarkers in chronic myofascial pain syndrome

Pain Medicine (United States)

Volumn 17, Issue 1, 2016, Pages 122-135

  Medeiros, Liciane F ^a,b   Caumo, Wolnei ^a,b   Dussán Sarria, Jairo ^a,b   Deitos, Alicia ^a,b   Brietzke, Aline ^a,b   Laste, Gabriela ^a,b   Campos Carraro, Cristina ^a   de Souza, Andressa ^a,b   Scarabelot, Vanessa L ^a   Cioato, Stefania G ^a   Vercelino, Rafael ^a,b   de Castro, Alexandre L ^a   Araújo, Alex Sander ^a   Belló Klein, Adriane ^a   Fregni, Felipe ^c   Torres, Iraci L S ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BDNF; Myofascial Pain; Oxidative Parameters

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; PROTEIN S100B; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ANALGESIC AGENT; TUMOR NECROSIS FACTOR;

ACTION POTENTIAL AMPLITUDE; ACUPUNCTURE NEEDLE; ADULT; AGED; ANALGESIA; ARTICLE; CELL DAMAGE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL SILENT PERIOD; DEEP INTRAMUSCULAR STIMULATION THERAPY; DOUBLE BLIND PROCEDURE; ELECTROACUPUNCTURE; ENZYME ACTIVITY; EVIDENCE BASED MEDICINE; FACTORIAL DESIGN; FEMALE; HUMAN; INTRACORTICAL FACILITATION; INTRACORTICAL INHIBITION; MOTOR EVOKED POTENTIAL; MUSCLE EXCITATION; MYOFASCIAL PAIN; NERVOUS SYSTEM PARAMETERS; NEUROMODULATION; NEUROPHYSIOLOGY; OXIDATIVE STRESS; PAIN INTENSITY; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION SYSTEM; TREATMENT DURATION; TREATMENT WITHDRAWAL; VISUAL ANALOG SCALE; METABOLISM; MIDDLE AGED; MYOFASCIAL PAIN SYNDROMES; PROCEDURES; YOUNG ADULT;

ADULT; AGED; ANALGESICS; BIOMARKERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; MYOFASCIAL PAIN SYNDROMES; PAIN MANAGEMENT; TRANSCRANIAL MAGNETIC STIMULATION; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84945343453     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12919     Document Type: Article

References (98)

1. Staud R. Future perspectives: Pathogenesis of chronic muscle pain. Best Pract Res Clin Rheumatol 2007;21:581–96.
2. Simons DG, Travell JG, Simons LS. Travell and Simons’ myofascial pain and dysfunction: The trigger point manual, Vol 1. Upper Half of Body. Baltimore: Williams & Wilkins; 1999.
3. Mense S, Gerwin RD. Muscle Pain: Understanding the Mechanisms, 1st edn. Heidelberg: Springer- Verlag; 2010.
4. Ren K, Dubner R. Interactions between the immune and nervous systems in pain. Nat Med 2010;16: 1267–76.
5. Benarroch EE. Pain-autonomic interactions: A selective review. Clin Auton Res 2001;11:343–9.
6. Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: Coincidence or consequence? J Neuroendocrinol 2001;13:1009–23.
7. Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: An application of muscle pain concepts to myofascial pain syndrome. J Body Mov Ther 2008;12:371–84.
8. Haas L, Portela LVC, Böhmer AE, Oses JP, Lara DR. Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res 2010;35:830–4.
9. Tanure MTA, Gomez RS, Hurtado RCL, Teixeira AL, Domingues RB. Increased serum levels of brainderived neurotropic factor during migraine attacks: A pilot study. J Headache Pain 2010;11:427–30.
10. Rabie MA, Mohsen M, Ibrahim M, El-Sawy Mahmoud R. Serum level of brain derived neurotrophic factor (BDNF) among patients with bipolar disorder. J Affect Disord 2014;162:67–72.
11. Perini F, D’Andrea G, Galloni E, et al. Plasma cytokine levels in migraineurs and controls. Headache 2005;45:926–31.
12. Rozen T, Swidan SZ. Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 2007;47:1050–5.
13. Neyal M, Yimenicioglu F, Aydeniz A, et al. Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg 2013;115:736–40.
14. Taha R, Blaise GA. Update on the pathogenesis of complex regional pain syndrome: Role of oxidative stress. Can J Anaesth 2012;59:875–81.
15. Chu J. Twitch-obtaining intramuscular stimulation (TOIMS): Long term observations in the management of chronic partial cervical radiculopathy. Electromyogr Clin Neurophysiol 2000;40:503–10.
16. Lee SH, Chen CC, Lee CS, Lin TC, Chan RC. Effects of needle electrical intramuscular stimulation on shoulder and cervical myofascial pain syndrome and microcirculation. J Chinese Med Assoc 2008;71:200–6.
17. Couto C, Souza ICC, Torres ILS, Fregni F. Paraspinal stimulation combined with trigger point needling and needle rotation for the treatment of myofascial. Pain Clin J Pain 2014;30:214–23.
18. Lefaucheur JP. Use of repetitive transcranial magnetic stimulation in pain relief. Expert Rev Neurother 2008;8:799–808.
19. Mhalla A, Baudic S, Ciampi De Andrade D, et al. Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. Pain 2011;152:1478–85.
20. Lefaucheur JP, Drouot X, Ménard-Lefaucheur I, Keravel Y, Nguyen JP. Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain. Neurology 2006;67:1568–74.
21. Angelucci F, Oliviero A, Pilato F, et al. Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis. Neuroreport 2004;15: 717–20.
22. Su TF, Zhao YQ, Zhang LH, et al. Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors. Eur J Pain 2012;16:624–35.
23. Cha MH, Nam TS, Kwak Y, Lee H, Lee BH. Changes in cytokine expression after electroacupuncture in neuropathic rats. Evid Based Complement Alternat Med 2012;2012:792765.
24. Yukimasa T, Tamagawa A, Uozumi T, et al. Highfrequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry 2006;39:52–9.
25. Túnez I, Montilla P, Muñoz M, et al. Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes. Neurosci Res 2006;56:91–5.
26. Tasset I, Drucker-Colín R, Peña J, et al. Antioxidantlike effects and protective action of transcranial magnetic stimulation in depression caused by olfactory bulbectomy. Neurochem Res 2010;35:1182–7.
27. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Inter Med 2001;134:663–94.
28. Simons DG, Dommerholt J. Myofascial pain syndromes – trigger points. J Musculoskelet Pain 2007; 15:39–46.
29. Tough EA, White AR, Richards S, Campbell J. Variability of criteria used to diagnose myofascial trigger point pain syndrome-Evidence from a review of the literature. Clin J Pain 2007;23:278–86.
30. Yap E-C. Myofascial pain–An overview. Ann Acad Med Singapore 2007;36:43–8.
31. Short EB, Borckardt JJ, Anderson BS, et al. Ten sessions of adjunctive left prefrontal rTMS significantly reduces fibromyalgia pain: A randomized, controlled pilot study. Pain 2011;152:2477–84.
32. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988: 283–6.
33. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 2000;406:147–50.
34. Chipchase L, Schabrun S, Cohen L, et al. A checklist for assessing the methodological quality of studies using transcranial magnetic stimulation to study the motor system: An international consensus study. Clin Neurophysiol 2012;123:1698–704.
35. Turgut N, Altun BU. Cortical disinhibition in diabetic patients with neuropathic pain. Acta Neurol Scand 2009;120:383–8.
36. Antal A, Terney D, Ku¨ hnl S, Paulus W. Anodal transcranial direct current stimulation of the motor cortex ameliorates chronic pain and reduces short intracortical inhibition. J Pain Symptom Manage 2010;39:890–903.
37. Greenberg BD, Ziemann U, Harmon A, Murphy DL, Wassermann EM. Decreased neuronal inhibition in cerebral cortex in obsessive–compulsive disorder on transcranial magnetic stimulation. Lancet 1998;352: 881–2.
38. Spampinato C, Aguglia E, Concerto C, et al. Transcranial magnetic stimulation in the assessment of motor cortex excitability and treatment of drugresistant major depression. IEEE Trans Neural Syst Rehabil Eng 2013;21:391–403.
39. Rothwell JC. Techniques and mechanisms of action of transcranial stimulation of the human motor cortex. J Neurosci Methods 1997;74:113–22.
40. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45–56.
41. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105:121–6.
42. Marklund S. Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. Mutat Res 1985;148:129–34.
43. Flohé L, Günzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984;105:114–21.
44. Reznick AZ, Packer L. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357–63.
45. Lebel CP, Ischiropoulos H, Bondys SC. Evaluation of the probe 2’,7’-dichiorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992;5: 227–31.
46. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75.
47. Gupta SK. Intention-to-treat concept: A review. Perspect Clin Res 2011;2:109–12.
48. White PF, Li S, Chiu JW. Electroanalgesia: Its role in acute and chronic pain management. Anesth Analg 2001;92:505–13.
49. Greif R, Laciny S, Mokhtarani M, et al. Transcutaneous electrical stimulation of an auricular acupuncture point decreases anesthetic requirement. Anesthesiology 2002;96:306–12.
50. Han JS. Acupuncture: Neuropeptide release produced by electrical stimulation of different frequencies. Trends Neurosci 2003;26:17–22.
51. Han JS. Acupuncture and endorphins. Neurosci Lett 2004;361:258–61.
52. Lee SJ, Lyu YS, Kang HW, et al. Antinociception of heterotopic electro-acupuncture mediated by the dorsolateral funiculus. Am J Chin Med 2007;35: 251–64.
53. Silva JRT, Silva ML, Prado WA. Analgesia induced by 2- or 100-Hz electroacupuncture in the rat tailflick test depends on the activation of different descending pain inhibitory mechanisms. J Pain 2011;12:51–60.
54. Kaelin-Lang A, Luft AR, Sawaki L, et al. Modulation of human corticomotor excitability by somatosensory input. J Physiol 2002;540:623–33.
55. Lo YL, Cui SL, Fook-Chong S. The effect of acupuncture on motor cortex excitability and plasticity. Neurosci Lett 2005;384:145–9.
56. Pleger B, Janssen F, Schwenkreis P, et al. Repetitive transcranial magnetic stimulation of the motor cortex attenuates pain perception in complex regional pain syndrome type I. Neurosci Lett 2004; 356:87–90.
57. Pagano RL, Assis DV, Clara JA, et al. Transdural motor cortex stimulation reverses neuropathic pain in rats: A profile of neuronal activation. Eur J Pain 2011;15: 268.e1–14.
58. On AY, Uludağ B, Taşkiran E, Ertekin C. Differential corticomotor control of a muscle adjacent to a painful joint. Neurorehabil Neural Repair 2004;18: 127–33.
59. Le Pera D, Graven-Nielsen T, Valeriani M, et al. Inhibition of motor system excitability at cortical and spinal level by tonic muscle pain. Clin Neurophysiol 2001;112:1633–41.
60. Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol 2003;2:145–56.
61. Maeda F, Keenan JP, Tormos JM, Topka H, Pascual-Leone A. Interindividual variability of the modulatory effects of repetitive transcranial magnetic stimulation on cortical excitability. Exp Brain Res 2000;133:425–30.
62. Rasmussen P, Brassard P, Adser H, et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 2009;94: 1062–9.
63. Karege F, Perret G, Bondolfi G, et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002;109: 143–8.
64. Woolf CJ. Neuronal plasticity: Increasing the gain in pain. Science 2000;288:1765–8.
65. Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: Do pain and memory share similar mechanisms? Trends Neurosci 2003;26:696–705.
66. Malcangio M, Lessmann V. A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends Pharmacol Sci 2003;24:116–21.
67. Biggs JE, Lu VB, Stebbing MJ, Balasubramanyan S, Smith PA. Is BDNF sufficient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization? Mol Pain 2010;6:44.
68. Schaller G, Sperling W, Richter-Schmidinger T, et al. Serial repetitive transcranial magnetic stimulation (rTMS) decreases BDNF serum levels in healthy male volunteers. J Neural Transm 2014;121:307–13.
69. Lang UE, Hellweg R, Gallinat J, Bajbouj M. Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: No effects on brain-derived neurotrophic factor (BDNF) concentrations in serum. J Affect Disord 2008;107:255–8.
70. Li Voti P, Conte A, Suppa A, et al. Correlation between cortical plasticity, motor learning and BDNF genotype in healthy subjects. Exp Brain Res 2011;212:91–9.
71. Gedge L, Beaudoin A, Lazowski L, et al. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry 2012;3:12.
72. Zanardini R, Gazzoli A, Ventriglia M, et al. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord 2006;91:83–6.
73. Cheeran B, Talelli P, Mori F, et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 2008;586: 5717–25.
74. Ga H, Choi JH, Park CH, Yoon HJ. Dry needling of trigger points with and without paraspinal needling in myofascial pain syndromes in elderly patients. J Altern Complement Med 2007;13:617–24.
75. Huguenin L, Brukner PD, McCrory P, et al. Effect of dry needling of gluteal muscles on straight leg raise: A randomised, placebo controlled, double blind trial. Br J Sports Med 2005;39:84–90.
76. Witt CM, Pach D, Brinkhaus B, et al. Safety of acupuncture: Results of a prospective observational study with 229,230 patients and introduction of a medical information and consent form. Forsch Komplementarmed 2009;16:91–7.
77. Machii K, Cohen D, Ramos-Estebanez C, Pascual-Leone A. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin Neurophysiol 2006;117:455–71.
78. Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol 2008;11:131–47.
79. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol off J Int Fed Clin Neurophysiol 2009; 120:2008–39.
80. Latremoliere A, Woolf CJ. Central sensitization: A generator of pain hypersensitivity by central neural plasticity. J Pain 2009;10:895–926.
81. Taves S, Berta T, Chen G, Ji RR. Microglia and spinal cord synaptic plasticity in persistent pain. Neural Plast 2013;2013:753656.
82. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin- 1beta, interleukin-6, and tumor necrosis factoralpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008;28: 5189–94.
83. Deitos A, Dussán-Sarria JA, de Souza A, et al. Clinical value of serum neuroplasticity mediators in identifying the central sensitivity syndrome in patients with chronic pain with and without structural pathology. Clin J Pain 2014. [Epub ahead of print].
84. Donato R, Sorci G, Riuzzi F, et al. S100B’s double life: Intracellular regulator and extracellular signal. Biochim Biophys Acta 2009;1793:1008–22.
85. Raabe A, Kopetsch O, Woszczyk A, et al. S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurol Res 2004;26:440–5.
86. Vos PE, Lamers KJB, Hendriks JCM, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62: 1303–10.
87. Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: Relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999;45:468–75; discussion 475–6.
88. Tian WN, Braunstein LD, Apse K, et al. Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am J Physiol 1999;276:C1121–31.
89. Jovanovic P, Zoric L, Stefanovic I, et al. Lactate dehydrogenase and oxidative stress activity in primary open-angle glaucoma aqueous humour. Bosn J Basic Med Sci 2010;10:83–8.
90. Jajte J, Grzegorczyk J, Zmysacute M, Rajkowska E. Effect of 7 mT static magnetic field and iron ions on rat lymphocytes: Apoptosis, necrosis and free radical processes. Bioelectrochemistry 2002;57:107–11.
91. Akdag MZ, Bilgin MH, Dasdag S, Tumer C. Alteration of nitric oxide production in rats exposed to a prolonged, extremely low-frequency magnetic field. Electromagn Biol Med 2007;26:99–106.
92. Simko M. Cell type specific redox status is responsible for diverse electromagnetic field effects. Curr Med Chem 2007;14:1141–52.
93. Guedes RP, Araújo ASR, Janner D, et al. Increase in reactive oxygen species and activation of Akt signaling pathway in neuropathic pain. Cell Mol Neurobiol 2008;28:1049–56.
94. Lee YS, Sindhu RK, Lin CY, et al. Effects of nerve graft on nitric oxide synthase, NAD(P)H oxidase, and antioxidant enzymes in chronic spinal cord injury. Free Radic Biol Med 2004;36:330–9.
95. Naik AK, Tandan SK, Dudhgaonkar SP, et al. Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-l-cysteine in rats. Eur J Pain 2006;10:573–9.
96. Rokyta R, Holecek V, Pekárková I, et al. Free radicals after painful stimulation are influenced by antioxidants and analgesics. Neuroendocrinol Lett 2003;24:304–9.
97. Blackwell TS, Christman JW. Sepsis and cytokines: Current status. Br J Anaesth 1996;77:110–7.
98. Sheeran P, Hall GM. Cytokines in anaesthesia. Br J Anaesth 1997;78:201–19.